Today: 9 June 2026
Reddit stock today: RDDT nudges up premarket after Needham keeps $300 target, CTO sale disclosed
30 December 2025
2 mins read

Reddit stock today: RDDT nudges up premarket after Needham keeps $300 target, CTO sale disclosed

NEW YORK, December 30, 2025, 06:10 ET — Premarket.

  • Reddit shares were up about 0.5% in premarket trading after a 3.9% rise in the prior session.
  • Needham reiterated its Buy rating on the stock, keeping a $300 price target.
  • A filing showed CTO Christopher Slowe sold shares under a pre-arranged trading plan.

Reddit’s shares were up about 0.5% at $235.70 in premarket trading on Tuesday, after jumping 3.9% to close at $234.65 in the previous session.

The move followed renewed focus on Reddit’s role in AI-driven search, after Needham reiterated a Buy rating and kept its $300 price target on Monday, according to GuruFocus.

Needham analyst Laura Martin argued that as “referral traffic” — the clicks that send users from one site to another — shrinks, the value shifts to where AI-generated answers point readers. “As overall referral traffic shrinks, the platforms that AI answers cite (like Reddit) become increasingly valuable, we believe,” Martin wrote. Investors.com

The timing matters because markets are navigating a holiday-thinned week in which rates-sensitive growth stocks can swing sharply on any shift in interest-rate expectations. Investors are also watching for the release of minutes from the Federal Reserve’s Dec. 9-10 meeting at 2 p.m. EST.

Separately, a Form 4 filing on Monday showed Reddit Chief Technology Officer Christopher Brian Slowe sold a total of 14,000 shares on Dec. 22 at prices ranging from $231.49 to $240.10, and reported holding 171,694 shares directly after the transactions.

The filing said the sales were made under a Rule 10b5-1 plan — a pre-arranged trading plan that can allow executives to buy or sell shares on a set schedule.

Reddit outperformed a softer broader market on Monday, when major U.S. indexes retreated as heavyweight tech names fell, Reuters reported. Reuters also flagged that trading volumes are expected to remain light with U.S. markets shut on Thursday for New Year’s Day.

Reddit has leaned into the pitch that its user discussions are becoming more valuable in a world of AI summaries. Needham, as summarized by TipRanks, pointed to studies suggesting Reddit accounts for roughly 20% to 40% of citations inside AI-generated answers — a shift that could reward platforms that get referenced even when users don’t click through.

The company has highlighted its scale: as of Sept. 30, it had 116 million daily active uniques, more than 443 million weekly active uniques, 100,000-plus active communities and 23 billion-plus posts and comments.

In its most recent quarterly report, Reddit said third-quarter revenue rose 68% year-on-year to $585 million, including ad revenue of $549 million, and it posted adjusted EBITDA of $236 million. It forecast fourth-quarter revenue of $655 million to $665 million and adjusted EBITDA of $275 million to $285 million.

At current levels, the stock’s valuation keeps it sensitive to any change in the growth outlook. Reddit’s shares trade at about 123 times earnings, based on the price-to-earnings ratio — a common yardstick for how much investors are paying for each dollar of profit.

Beyond the Fed minutes later in the day, traders have a busy U.S. calendar to navigate: the Dallas Fed’s Texas Retail Outlook Survey is scheduled for 10:30 a.m. ET, while weekly jobless claims are scheduled for release on Wednesday, Dec. 31 at 8:30 a.m. ET due to the holiday-week adjustment.

Stock Market Today

  • AmpliTech Shares Surge 26.7% on 5G Open RAN Testing Update
    June 9, 2026, 9:16 AM EDT. AmpliTech (AMPG) shares surged 26.7% to $6.57 following its Open RAN testing update at the O-RAN Alliance Global PlugFest Spring 2026. The company's 64T64R Massive MIMO radio, which uses multiple antennas to enhance wireless capacity, was the only one of its kind tested with equipment from major operators including AT&T and Deutsche Telekom. Despite the strong test results, no new sales orders were announced, leaving investors cautious about future revenue impact. AmpliTech reported a 48.6% increase in first-quarter revenue to $5.35 million but remains unprofitable, narrowing its net loss to $1.52 million. The firm holds $18.4 million in cash and securities. Open RAN aims to enable multi-vendor interoperability in 5G networks, a critical push in telecom infrastructure modernization.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop